Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Detection, verification, and quantification of adverse drug reactions.

Literature DB >> 15231627

Detection, verification, and quantification of adverse drug reactions.

Bruno H Ch Stricker¹, Bruce M Psaty.

Abstract

Mesh：

Year: 2004 PMID： 15231627 PMCID： PMC443457 DOI： 10.1136/bmj.329.7456.44

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

18 in total

1. In defense of case reports and case series.

Authors: J P Vandenbroucke
Journal: Ann Intern Med Date: 2001-02-20 Impact factor: 25.391

Review 2. Lessons from the glitazones: a story of drug development.

Authors: E A Gale
Journal: Lancet Date: 2001-06-09 Impact factor: 79.321

Review 3. The use of evidence in pharmacovigilance. Case reports as the reference source for drug withdrawals.

Authors: J A Arnaiz; X Carné; N Riba; C Codina; J Ribas; A Trilla
Journal: Eur J Clin Pharmacol Date: 2001-04 Impact factor: 2.953

4. Serum sickness-like reactions to cefaclor.

Authors: B H Stricker; J G Tijssen
Journal: J Clin Epidemiol Date: 1992-10 Impact factor: 6.437

5. Power and weakness of spontaneous reporting: a probabilistic approach.

Authors: P Tubert; B Bégaud; J C Péré; F Haramburu; J Lellouch
Journal: J Clin Epidemiol Date: 1992-03 Impact factor: 6.437

6. ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in prescription-event monitoring.

Authors: K Kubota; N Kubota; G L Pearce; W H Inman
Journal: Eur J Clin Pharmacol Date: 1996 Impact factor: 2.953

Review 7. False-positives in spontaneous reporting: should we worry about them?

Authors: B Begaud; Y Moride; P Tubert-Bitter; A Chaslerie; F Haramburu
Journal: Br J Clin Pharmacol Date: 1994-11 Impact factor: 4.335

8. The need for randomization in the study of intended effects.

Authors: O S Miettinen
Journal: Stat Med Date: 1983 Apr-Jun Impact factor: 2.373

9. Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems.

Authors: G R Venning
Journal: Br Med J (Clin Res Ed) Date: 1983-02-05

10. Confounding by contraindication in a nationwide cohort study of risk for death in patients taking ibopamine.

Authors: H Feenstra; R E Grobbee; B A in't Veld; B H Stricker
Journal: Ann Intern Med Date: 2001-04-03 Impact factor: 25.391

67 in total

1. Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study.

Authors: Maarten J Ten Berg; Patricia M L A van den Bemt; Sumitra Shantakumar; Dimitri Bennett; Emile E Voest; Albert Huisman; Wouter W van Solinge; Toine C G Egberts
Journal: Drug Saf Date: 2011-12-01 Impact factor: 5.606

2. Balancing benefits and harms in health care: technology to collect and share information about harms already exists.

Authors: Paul L Cervi
Journal: BMJ Date: 2004-08-21

Review 3. Impact of safety-related regulatory action on clinical practice: a systematic review.

Authors: Sigrid Piening; Flora M Haaijer-Ruskamp; Jonie T N de Vries; Menno E van der Elst; Pieter A de Graeff; Sabine M J M Straus; Peter G M Mol
Journal: Drug Saf Date: 2012-05-01 Impact factor: 5.606

4. Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.

Authors: Arna H Arnardottir; Flora M Haaijer-Ruskamp; Sabine M J Straus; Pieter A de Graeff; Peter G M Mol
Journal: Drug Saf Date: 2011-11-01 Impact factor: 5.606